drugset / Trial / NCT05188417
A Study Evaluating the Safety and Efficacy of Tirofiban in Combination With Alteplase in Acute Ischemic Stroke
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The study is a prospective, multicenter, randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of tirofiban in combination with intravenous thrombolytic therapy with alteplase in acute ischemic stroke
Timeline
- Start
- 2021-12-09
- Primary completion
- 2023-03-30
- Completion
- 2023-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tirofiban | Other / unclassified | 0.1 ug/kg | Intravenous |